The 2025 issues are currently available for preorder. Issue 22A will be available in April 2025. Issue 22B will be available in October 2025.

After successfully completing this activity, the learner will be able to

• Assess the current state of his or her knowledge of fundamental and subspecialty anesthesia topics and identify knowledge gaps
• Develop a strategy to address identified gaps using resources provided as references within the program
• Utilize enhanced knowledge in clinical practice to enhance patient safety and prevent harm

This activity is intended for anesthesiologists, anesthesia residents, and members of the anesthesia care team.

Faculty and Credentials

Bhargavi Gali, MD, MHA, Co-Editor-in-Chief
Rochester, Minnesota

Stacy L. Jones, MD, MHA, FASA, Co-Editor-in-Chief
Austin, Texas

Anuj K. Aggarwal, MD
Stanford, California

Shamsuddin Akhtar, MD
New Haven, Connecticut

Vaibhav Bora, MBBS, FASE, FCCM, FCCP
Augusta, Georgia

Russell K. McAllister, MD, FASA
Temple, Texas

Shobana Rajan, MD, FASA
Cleveland, Ohio

Sara Robertson, MD, FASA
Madison, Mississippi

Kasia Rubin, MD, MBA
Cleveland, Ohio

Ahmed Shalabi, MBBCh, MSc, FCAI
Los Angeles, California

Kofi B. Vandyck, MD
Oklahoma City, Oklahoma

Christine T. Vo, MD, FASA
Oklahoma City, Oklahoma

Maheen A. Wardak, MD
Houston, Texas

ASA Staff: Ginger Clark, Managing Editor

Resolution of Conflicts of Interest: ASA remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of ASA to eliminate all situations of potential conflict of interest, but rather to enable those who are working with ASA to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. ASA educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ASA activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The faculty and staff below have reported the following financial relationships with ineligible companies:
Ginger Clark
Merck: Stock (self)
Organon & Co: Stock (self)
All disclosed financial relationships have been mitigated. All other faculty, planners, and staff have reported no financial relationships with ineligible companies.

Internet connection. Web browser: Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari, updated within the last 3 years.